Atlas Trials

A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer Patients

Clinical trial NCT01183494 · COMPLETED

Trial details

NCT number
NCT01183494
Sponsor
University of Chicago
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2009-12-12
Primary completion
2017-06-02
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.